allopurinol + ascorbic acid + cyclodextrin

A combination drug consisting of **allopurinol** (a xanthine oxidase inhibitor primarily used to lower uric acid levels), **ascorbic acid** (Vitamin C, an antioxidant and reducing agent), and **cyclodextrin** (a cyclic oligosaccharide often used to enhance the solubility and stability of pharmaceutical compounds). - **Mechanism of Action**: - Allopurinol inhibits **xanthine oxidase**, lowering serum and urine uric acid concentrations and reducing risk of gout and kidney stones[1][7]. - Ascorbic acid participates in redox reactions and may enhance antioxidant capacity in blood, potentially influencing cardiovascular or metabolic endpoints[2]. - Cyclodextrin acts as a carrier and solubilizer for the other drugs, shown experimentally to improve the dissolution and pharmacokinetic properties of allopurinol and facilitate the quantification/interaction with uric acid and ascorbic acid[2][6]. - **Primary Indication**: Although not a marketed product, this combination may be used for enhanced management of hyperuricemia or gout, possibly improving solubility, bioavailability, and assay sensitivity for uric acid and ascorbic acid in serum[2][6].